Dr. Ritesh Patil, MD, MPH

Dr. Patil practices at Health First Medical Group in Rockledge, Florida.

Dr. Patil's NPI, 1699892695, was assigned on March 23, 2007. Dr. Patil graduated from Nehru Medical College/ R. Gandhi HS University in 2004. Dr. Patil holds Florida license ME126569.

Dr. Patil's primary practice is Health First Medical Group, at 3300 S Fiske Blvd, Rockledge, FL 32955 in Brevard County. The practice phone is (321) 434-5055.

Dr. Patil's primary practice is Health First Medical Group in Rockledge, Florida. Dr. Patil is also affiliated with AdventHealth Orlando. The medical group on file is Health First Medical Group (Formerly Mima). Dmand AI also links Dr. Patil to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patil practices, 7 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Patil's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Patil is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Patil's licenses on file in 3 states: Florida, New York and Pennsylvania.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Dr. Patil treats.

CMS data shows 80,548 Medicare services from Dr. Patil across 35 procedure codes in 2024, for 801 Medicare patients. Medicare paid $511,094 for them.

CMS counts 801 Medicare patients who saw Dr. Patil in 2024. The largest group is 65 to 74, with 341 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Patil's median patient age at 71, with 59% women.

In 2024, Dr. Patil wrote 1,601 Medicare Part D claims for 343 patients. 80% of them were for generic drugs. CMS names the drug for 1,329 of them, across 36 drugs with 11 or more claims each, at $2,283,879 in total drug cost. In 2023, CMS named 981 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Patil for performance year 2024, reported through an alternative payment model (APM). Dr. Patil accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Patil as offering telehealth.

Dmand AI links 7 papers to Dr. Patil, published from 2009 to 2011. 2009 was the busiest year, with 2. The most frequent topics are Breast Neoplasms, Cancer Vaccines and Receptor, ErbB-2. Dr. Patil has published most often in J Gen Intern Med. Dr. Patil's most frequent co-authors are Guy Travis Clifton, MD, Jarrod Paul Holmes, MD and Alexander Stojadinovic, MD.

CMS Open Payments shows 182 general payments to Dr. Patil from 32 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 94% of the total. Pfizer Inc. paid the most, $555.

Dr. Patil graduated from Nehru Medical College/ R. Gandhi HS University in 2004.

Dr. Patil is in network with 14 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.